Latest Articles for Cancer Treatment

New nanopore technology offers rapid measurements of radiation-induced DNA damage.

Integrating AI and patient data enhances cancer treatment for better outcomes.

Researchers enhance Compton cameras for better proton therapy monitoring.

New methods are enhancing CAR development through machine learning innovations.

Tarlatamab shows promise for patients with small cell lung cancer.

Researchers are finding innovative ways to tackle glioblastoma and improve patient outcomes.

A look at how tech is reshaping esophageal cancer surgery.

A study focuses on muscle function during chemotherapy to improve patient quality of life.

Artificial intelligence is changing patient care in bladder cancer.

This study examines temperature monitoring methods during HIPEC and their implications.

A new algorithm enhances radiation therapy efficiency and accuracy in cancer care.

Exploring the role and challenges of surrogate endpoints in cancer treatment evaluations.

Discover how CAR T cell therapy is changing cancer treatment for patients.

New deep learning techniques improve tumor segmentation in head and neck cancer treatments.

Exploring how community conditions shape health care experiences for cancer patients.

A new model aims to personalize chemotherapy using genetic profiles for better outcomes.

Learn how microdosimetry improves cancer treatment by correcting data distortions.

Combining SHP2 and BRAF inhibitors shows promise in fighting stubborn gliomas.

Molecular glues promise new therapies by targeting hard-to-reach proteins.

Scientists use DNA origami to improve targeted drug delivery for diseases.

Research reveals genetic factors influencing cancer treatment responses.

FLASH radiotherapy offers a faster, more effective approach to cancer treatment.

Discover how imaging is changing drug dosing strategies for better cancer treatment.

New techniques are enhancing tumor segmentation in head and neck cancer treatment.

A fresh approach to predicting effective cancer drug combinations.

New FLUKA version improves accuracy in proton radiation therapy simulations.

Pyrotinib shows promise in reducing cancer recurrence for high-risk patients.